Drug intelligence / Profile preview

N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate

Development stage
Unknown
Modality
Small Molecules
01

Overview

N-Pyridoxyl–1-Amino–Cyclopropanecarboxylic Acid–5-Monophosphate is a synthetic small molecule containing a pyridoxamine (vitamin B6 derivative) moiety with a phosphate group at the 5' position, linked to an aminocyclopropanecarboxylic acid. It is primarily of interest as an experimental compound in biochemical and medicinal chemistry research, particularly for its structural features—such as the cyclopropane ring and phosphono group—which may influence interactions with enzymes or receptors. There are no approved therapeutic indications or known clinical uses for this compound, and it has not advanced beyond experimental status in drug development[1][2][6].

Other names
N-PYRIDOXYL-1-AMINO-CYCLOPROPANECARBOXYLIC ACID-5-MONOPHOSPHATEN-PYRIDOXYL1-AMINO-CYCLOPROPANECARBOXYLIC ACID-5-MONOPHOSPHATEN-PYRIDOXYL 1-AMINO-CYCLOPROPANECARBOXYLIC ACID-5-MONOPHOSPHATE1-[({3-hydroxy-2-methyl-5-(phosphonooxy)methyl]pyridin-4-y-l}methyl)amino]cyclopropane carboxylic acidn-[3-hydroxy-2-methyl–5-phosphonooxymethyl-pyridin–4-y-lmethyl]-1-amino-cyclopropanecarboxylic acid
02

Targets

ACS (Acetyl-CoA synthetase)

Beyond the preview

Go deeper on N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call